Eyeworld

EW MEETING REPORTER 78 May 2016 Reporting from OIS@ASCRS, May 5, 2016 New Orleans Refocus Group (Dallas), ReVision Optics (Lake Forest, California), Encore Vision (Fort Worth, Texas), ClarVista Medical (Aliso Viejo, Cal- ifornia), Mynosys Cellular Devices (Fremont, California), International Biomedical Devices (Austin, Texas), Cassini (i-Optics, The Hague, the Netherlands), TearScience (Morrisville, North Carolina), Aerie Pharmaceuticals (Irvine, California), ForSight VISION5 (Menlo Park, California), Ocular Therapeutix (Bedford, Massachusetts), and Avedro (Waltham, Massachusetts). Following the company show- case, Richard Lindstrom, MD, Min- neapolis, gave a market overview, looking at the impact of diagnos- tics on the premium channel. The session included company presen- tations from TearLab (San Diego), Alcon (Fort Worth, Texas), Carl Zeiss Meditec (Jena, Germany), and Heidelberg Engineering (Heidelberg, Germany). A panel also discussed Dr. Link highlighted several principles of innovation, which include innovation focused on important big opportunities, seeking the truth, being disciplined, trying things, being willing to fail, not being paralyzed by mistakes, being skilled, being aggressive and asser- tive but not arrogant, and being professional. Innovation happens where the innovators are and where the culture allows and fosters innova- tion, Dr. Link said. "The larger an organization is, the tougher it is to keep innovating." There is still an immense unmet need, he added, and resources are focused where they are rewarded. Innovation in the ophthalmic sector is gaining momentum, Dr. Link said. This year's Ophthalmology Innovation Showcase portion of the program featured company presentations with speakers from PowerVision (Belmont, California), T he Ophthalmology Innova- tion Summit (OIS) at ASCRS (OIS@ASCRS) took place on Thursday, May 5, prior to the 2016 ASCRS•ASOA Symposium & Congress. As in past years, the meeting offered attendees an update on the innovation cycle and financing topics in ophthal- mology. There were also company presentations, as well as sessions de- signed to highlight anterior segment topics. William Link, PhD, San Fran- cisco, kicked off the meeting with an update on the OIS meeting and the innovation cycle. "We have a special opportunity to get the constituents that are necessary and required for innovation altogether in 1 meeting," he said. This year's meeting marked the 12th OIS meeting and 5th OIS@ ASCRS. With about 500 attendees, it was also the largest so far at ASCRS and has expanded from a half day to nearly a full day of programming. Reporting from OIS@ASCRS After receiving the OIS Lifetime Innovator Award, Dr. Steinert spoke with Dr. Lane about his career and advice for young ophthalmologists. Sponsored by

• Cover